Chronic myelogenous leukemia (CML) is a clonal hematologic malignancy of the myeloid lineage caused by the oncogenic BCR/ABL fusion protein that promotes CML cell proliferation and protects them against drug-induced apoptosis. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.